# Viokace

NDC: 73562-208
Generic name: Pancrelipase
Labeler / Manufacturer: Aimmune Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: TABLET
Routes: ORAL
Marketing started: 20210301

FDA application: BLA022542

## Active ingredients

- PANCRELIPASE AMYLASE: 78300 [USP'U]/1
- PANCRELIPASE LIPASE: 20880 [USP'U]/1
- PANCRELIPASE PROTEASE: 78300 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73562-208"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73562-208
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=58bdb8de-582d-44e6-9b72-8d5a42fdf501